Estimating meaningful change for The Impact of Weight on Self-Perception (IW-SP) questionnaire among people with type 2 diabetes

por Gelhorn, Heather L., Maher, Stephen, Sapin, Helene, Poon, Jiat Ling, Boye, Kristina
Publicado 2023

Improved Glycaemic and Weight Management Are Associated with Better Quality of Life in People with Type 2 Diabetes Treated with Tirzepatide

por Boye, Kristina S., Sapin, Hélène, Dong, Wenxiu, Williamson, Suzanne, Lee, Clare J., Thieu, Vivian Thuyanh
Publicado 2023

Once-Weekly Exenatide Versus Once- or Twice-Daily Insulin Detemir: Randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metfo...

por Davies, Melanie, Heller, Simon, Sreenan, Seamus, Sapin, Hélène, Adetunji, Omolara, Tahbaz, Arash, Vora, Jiten
Publicado 2013

GLP-1 RA Treatment Patterns Among Type 2 Diabetes Patients in Five European Countries

por Divino, Victoria, DeKoven, Mitch, Khan, Farhad Ali, Boye, Kristina S., Sapin, Hélène, Norrbacka, Kirsi
Publicado 2017

Inhibition/activation in bipolar disorder: validation of the Multidimensional Assessment of Thymic States scale (MAThyS)

por Henry, Chantal, Luquiens, Amandine, Lançon, Christophe, Sapin, Hélène, Zins-Ritter, Marcel, Gerard, Stephanie, Perrin, Elena, Falissard, Bruno, Lukasiewicz, Michael
Publicado 2013

Efficacy of tirzepatide 5, 10 and 15 mg versus semaglutide 2 mg in patients with type 2 diabetes: An adjusted indirect treatment comparison

por Vadher, Karan, Patel, Hiren, Mody, Reema, Levine, Joshua A., Hoog, Meredith, Cheng, Alice YY., Pantalone, Kevin M., Sapin, Hélène
Publicado 2022

Using Exenatide Twice Daily or Insulin in Clinical Practice: Results from CHOICE

por Mathieu, Chantal, Östenson, Claes-Göran, Matthaei, Stephan, Reaney, Matthew, Krarup, Thure, Guerci, Bruno, Kiljański, Jacek, Salaun-Martin, Carole, Sapin, Hélène, Theodorakis, Michael
Publicado 2013

Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study

por Reaney, Matthew, Mathieu, Chantal, Östenson, Claes-Göran, Matthaei, Stephan, Krarup, Thure, Kiljański, Jacek, Salaun-Martin, Carole, Sapin, Hélène, Theodorakis, Michael, Guerci, Bruno
Publicado 2013

The Real‐World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Patients with Type 2 Diabetes (TROPHIES): Patient disposition, clinical chara...

por Guerci, Bruno, Giorgino, Francesco, Sapin, Hélène, Boye, Kristina, Lebrec, Jérémie, Federici, Marco Orsini, Heitmann, Elke, Dib, Anne, Füchtenbusch, Martin, García‐Pérez, Luis‐Emilio
Publicado 2022

Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries

por Östenson, Claes-Göran, Matthaei, Stephan, Reaney, Matthew, Krarup, Thure, Guerci, Bruno, Kiljanski, Jacek, Salaun-Martin, Carole, Sapin, Hélène, Bruhn, David, Mathieu, Chantal, Theodorakis, Michael
Publicado 2013

Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study

por Kiiskinen, Urpo, Matthaei, Stephan, Reaney, Matthew, Mathieu, Chantal, Östenson, Claes-Göran, Krarup, Thure, Theodorakis, Michael, Kiljański, Jacek, Salaun-Martin, Carole, Sapin, Hélène, Guerci, Bruno
Publicado 2013

The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Baseline Patient-Reported Outcomes

por Boye, Kristina S., Sapin, Hélène, García-Pérez, Luis-Emilio, Rosilio, Myriam, Orsini Federici, Marco, Heitmann, Elke, Jung, Heike, Aigner, Ulrich, Guerci, Bruno, Giorgino, Francesco, Norrbacka, Kirsi
Publicado 2020

Patient-Reported Outcomes in People with Type 2 Diabetes Receiving Tirzepatide in the SURPASS Clinical Trial Programme

por Boye, Kristina S., Thieu, Vivian Thuyanh, Sapin, Hélène, Lee, Clare J., Landó, Laura Fernández, Brown, Katelyn, Bray, Ross, Wiese, Russell J., Patel, Hiren, Rodríguez, Ángel, Yu, Maria
Publicado 2023

The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Design and Baseline Characteristics

por García-Pérez, Luis-Emilio, Boye, Kristina S., Rosilio, Myriam, Jung, Heike, Heitmann, Elke, Norrbacka, Kirsi, Federici, Marco Orsini, Gentilella, Raffaella, Guerci, Bruno, Giorgino, Francesco, Aigner, Ulrich, Sapin, Hélène
Publicado 2021